U.S. and U.S. experts find Par-4 tumor suppressor gene in prostate
-
Last Update: 2020-07-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
researchers at the University of Kentucky have developedin mice that fight cancer,the achievement was inspired by atumorinhibition gene found in the prostate by Vivek Langnecar, a professor at the British School of Medicine, and his team, the Daily Science website reportedThe researchers foundthatthe "Par-4" gene kills cancer cells,but does not harm normal cellsAs a result,, the"Par-4" gene has the potential to treat cancerLangnecar produced a mouse with the "Par-4" gene and compared it to other mice, the report saidIt turns out that the "Par-4" gene does fight cancer cells, and that the gene does not have any toxic side effects"We first found the 'Par-4' gene in the prostate, but it's not limited to the prostate, " Langnecal said The gene, which is present in every type of cell we studied, kills a variety of cancer cells, including, of course, cancer cells in the prostate The interesting part of the study is that the 'killer' gene kills cancer cells without killing normal cells "
to further investigate the potential therapeutic effects of the gene, Langnecal's team injected it into the egg of a mouse and implanted it into the surrogate female "The mouse itself didn't replicate a lot of this gene, but its young mice copied a lot of it, " Langnekar said As a result, we were able to pass this gene-replicating behavior from generation to generation in mice "
this means to humans that the "Par-4" gene can be used to deal with cancer cells in patients through bone marrow transplants, which do not produce toxic side effects of chemotherapy and radiotherapy
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.